Treatment of fibromyalgia and chronic fatigue syndrome

Details Treatment of fibromyalgia and chronic fatigue syndrome Treatment of fibromyalgia and chronic fatigue syndrome

A - Human Necessities

61

K

A61K 31/505 (2006.01) A61K 31/40 (2006.01) A61K 31/404 (2006.01) A61K 31/445 (2006.01) A61K 31/454 (2006.01) A61K 31/47 (2006.01) A61K 31/4748 (2006.01) A61K 31/48 (2006.01) A61K 31/519 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2404704

The present invention relates to the treatment of neuromuscular disorders and, more specifically, to the use of apomorphine, bromocriptine, pergolide, ropinirole, octahydropyrazolo[3,4-g]quinolines, and trans-(.plusmn.)- substituted-5,5a,6,7,8,9-,9a,10-octahydropyrimido[4,5g]quinolines, and their pharmaceutically acceptable salts to treat, or to prepare a medicament for treating, symptoms of fibromyalgia syndrome and chronic fatigue syndrome.

La présente invention concerne le traitement de troubles neuromusculaires et plus précisément, l'emploi d'apomorphine, de bromocriptine, de pergolide, de ropinirole, d'octahydropyrazolo[3,4-g]quinolines, et de -5,5a,6,7,8,9-,9a,10-octahydropyrimido[4,5g]quinolines trans-(.plusmn.)-substituées, ainsi que des sels pharmaceutiquement acceptables de ces composés pour le traitement, ou la préparation de médicaments, pour le traitement des symptômes de la cellulomyalgie et du syndrome de fatigue chronique.

Affiliated with

Also associated with

Rating

Treatment of fibromyalgia and chronic fatigue syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of fibromyalgia and chronic fatigue syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of fibromyalgia and chronic fatigue syndrome will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1835420